Letters
Non-alcoholic fatty liver disease and cardiovascular risk
Studies on non-alcoholic fatty liver disease should stratify by disease severity
BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6495 (Published 22 November 2019) Cite this as: BMJ 2019;367:l6495
- Matthew T McKenna-Barry, registrar,
- John D Ryan, consultant hepatologist
- Hepatology Unit, Beaumont Hospital / Royal College of Surgeons in Ireland, Dublin 9, Republic of Ireland
- matthewmckennabarry{at}beaumont.ie
In a large, population based cohort study, Alexander and colleagues report that a diagnosis of non-alcoholic fatty liver disease (NAFLD) does not confer an increased risk of ischaemic heart disease or stroke.1 To translate these findings into clinical practice, we must appreciate the spectrum of NAFLD severity, especially as patients with advanced fibrosis have …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £138 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.